Published in Scand J Gastroenterol Suppl on January 01, 1988
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. Proc Natl Acad Sci U S A (1993) 2.44
Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J Bacteriol (1993) 1.85
Comparison of Helicobacter pylori and attaching-effacing Escherichia coli adhesion to eukaryotic cells. Infect Immun (1993) 1.67
Receptor-mediated adherence of Campylobacter pylori to mouse Y-1 adrenal cell monolayers. Infect Immun (1989) 1.50
Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa. J Clin Pathol (1994) 1.44
Optimal survival of Helicobacter pylori under various transport conditions. J Clin Microbiol (1992) 1.44
Relation of Helicobacter pylori to the human gastric mucosa in chronic gastritis of the antrum. Gut (1990) 1.38
Helicobacter pylori is invasive and it may be a facultative intracellular organism. Cell Microbiol (2007) 1.33
Characterization of feline Helicobacter pylori strains and associated gastritis in a colony of domestic cats. J Clin Microbiol (1995) 1.26
The putative neuraminyllactose-binding hemagglutinin HpaA of Helicobacter pylori CCUG 17874 is a lipoprotein. J Bacteriol (1995) 1.23
Further evidence of the toxic effect of ammonia produced by Helicobacter pylori urease on human epithelial cells. Infect Immun (1992) 1.09
Adhesion of Helicobacter pylori to polarized T84 human intestinal cell monolayers is pH dependent. Infect Immun (1996) 1.08
Assessment of invasion frequencies of cultured HEp-2 cells by clinical isolates of Helicobacter pylori using an acridine orange assay. J Clin Pathol (1998) 1.06
Helicobacter pylori interactions with host serum and extracellular matrix proteins: potential role in the infectious process. Microbiol Mol Biol Rev (2002) 0.95
Successful cultivation of a potentially pathogenic coccoid organism with trophism for gastric mucin. Infect Immun (1997) 0.93
Mucin exocytosis: a major target for Helicobacter pylori. J Clin Pathol (1993) 0.93
Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut (1997) 0.90
Human embryonic gastric xenografts in nude mice: a new model of Helicobacter pylori infection. Infect Immun (1999) 0.87
Agglutination of Helicobacter pylori coccoids by lectins. World J Gastroenterol (2000) 0.85
Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine. Gut (1995) 0.83
Gastric penetration of amoxicillin in a human Helicobacter pylori-infected xenograft model. Antimicrob Agents Chemother (1999) 0.82
Electron microscopic evaluation of adhesion of Helicobacter pylori to the gastric epithelial cells in chronic gastritis. Korean J Intern Med (2002) 0.82
Influence of Lewis antigen expression by Helicobacter pylori on bacterial internalization by gastric epithelial cells. Infect Immun (2003) 0.81
Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier. World J Gastroenterol (2015) 0.79
Celecoxib inhibits Helicobacter pylori colonization-related factors. World J Gastroenterol (2010) 0.79
Unidentified intralesional and intracellular coccoid microorganism discovered in the young man with a diffuse erosive gastroduodenitis and multiple superficial ulcerations. BMJ Case Rep (2014) 0.75
Ultrastructural changes in non-specific duodenitis. World J Gastroenterol (2005) 0.75
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83
The coccoid forms of Helicobacter pylori. Criteria for their viability. Epidemiol Infect (1993) 2.61
A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut (1997) 2.32
Structured reporting of medical findings: evaluation of a system in gastroenterology. Methods Inf Med (1992) 2.30
Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn. Aliment Pharmacol Ther (2013) 2.13
Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori. Aliment Pharmacol Ther (2014) 2.11
Characterization of yellow plaques found in the small bowel during double-balloon enteroscopy. Endoscopy (2007) 2.06
Diagnostic and therapeutic impact of double-balloon enteroscopy. Endoscopy (2006) 2.03
[The diagnostic value of the amino acid absorption test in detection of a disorder of exocrine pancreatic function]. Z Gastroenterol (1992) 2.02
Analysis of nerves in chronic pancreatitis. Gastroenterology (1988) 2.01
[Short guideline for the management of dyspepsia]. Dtsch Med Wochenschr (2004) 2.01
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis (2011) 1.80
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
A retrospective analysis of emergency double-balloon enteroscopy for small-bowel bleeding. Endoscopy (2009) 1.72
Incidence of bleeding lesions within reach of conventional upper and lower endoscopes in patients undergoing double-balloon enteroscopy for obscure gastrointestinal bleeding. Aliment Pharmacol Ther (2008) 1.70
The role of infection in acute pancreatitis. Gut (1999) 1.66
Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori. Gastroenterology (1993) 1.66
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori. Helicobacter (1998) 1.61
Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol Res Pract (2008) 1.57
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.56
Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany. Z Gastroenterol (2003) 1.52
13C-urea breath test for the diagnosis of Helicobacter pylori infection. A further simplification for clinical practice. Scand J Gastroenterol (1998) 1.48
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47
Interdigestive cycling in chronic pancreatitis: altered coordination among pancreatic secretion, motility, and hormones. Gastroenterology (1995) 1.47
The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer (2000) 1.46
Biliary strictures are not the cause of pain in patients with chronic pancreatitis. Pancreas (2004) 1.44
Decision-making in dyspepsia: controversies in primary and secondary care. Eur J Gastroenterol Hepatol (1999) 1.43
[Endogenous prostaglandin synthesis and gastritis: lack of correlation with endoscopic findings, Helicobacter colonization and leukocytic infiltration of the mucosa]. Z Gastroenterol (1992) 1.41
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40
[Order in the chaos of classifications of erosions of the gastric mucosa]. Leber Magen Darm (1993) 1.39
Coccoid like forms (CLF) of Helicobacter pylori. Enzyme activity and antigenicity. Zentralbl Bakteriol (1993) 1.38
Increased risk for Helicobacter pylori recurrence by continuous acid suppression: a randomized controlled study. Ital J Gastroenterol Hepatol (1998) 1.38
[Polymorphism in Helicobacter pylori--a key function in recurrence of infection?]. Med Klin (Munich) (1992) 1.37
Increased incidence of gallstones and prior cholecystectomy in patients with large bowel cancer. Am J Gastroenterol (1992) 1.37
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol (2001) 1.35
Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut (1986) 1.32
Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology (1992) 1.31
Ultrastructural localisation of urease in outer membrane and periplasm of Campylobacter pylori. J Clin Pathol (1989) 1.29
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology (1999) 1.27
Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol (1995) 1.27
Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol (1992) 1.26
A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut (1999) 1.26
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol (2000) 1.26
Role of phospholipase A2 in human acute pancreatitis. Gastroenterology (1989) 1.20
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19
Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma. Int J Cancer (1997) 1.18
ERCP using single-balloon instead of double-balloon enteroscopy in patients with Roux-en-Y anastomosis. Endoscopy (2008) 1.18
Helicobacter pylori infection: a clinical overview. Dig Liver Dis (2008) 1.17
Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility. J Clin Microbiol (2006) 1.17
The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol (1998) 1.16
Diagnosis of Helicobacter pylori infection by HpSA test. European Helicobacter pylori HpSA Study Group. Lancet (1999) 1.16
Review article: helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther (2004) 1.16
Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1. Br J Cancer (2002) 1.16
Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer (1998) 1.15
A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharmacol Ther (2001) 1.14
PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas (1991) 1.14
The quality of gastroenterological reports based on free text dictation: an evaluation in endoscopy and ultrasonography. Endoscopy (1991) 1.14
Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction. Am J Gastroenterol (1994) 1.14
Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut (1998) 1.14
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut (1997) 1.13
Changes in peptidergic innervation in chronic pancreatitis. Pancreas (1992) 1.12
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther (2002) 1.10
Treatment of Helicobacter pylori. Best Pract Res Clin Gastroenterol (2007) 1.10
Duodenum-preserving pancreatic head resection: Long-term results. J Gastrointest Surg (2006) 1.10
Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol (1998) 1.08
The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut (1998) 1.08
Expression of carbonic anhydrase 9 at the invasion front of gastric cancers. Gut (2005) 1.08
Identification of structures containing polyphosphate in Helicobacter pylori. J Gen Microbiol (1993) 1.06
Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia (1981) 1.06
Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol (1996) 1.05
Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors. Am J Gastroenterol (1993) 1.03
[Direct stimulation of insulin secretion in vitro by scretion]. Dtsch Med Wochenschr (1965) 1.03
Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis. Dig Dis Sci (1998) 1.02
Chromoendoscopy: from a research tool to clinical progress. Dig Dis (2002) 1.02
A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs (1999) 1.02
Ultrastructural localization of urease of Helicobacter pylori. Med Microbiol Immunol (1993) 1.02
Interaction of receptors for insulin-like growth factor I, platelet-derived growth factor, and fibroblast growth factor in rat aortic cells. Endocrinology (1987) 1.02
Double-balloon enteroscopy-assisted virtual chromoendoscopy for small-bowel disorders: a case series. Endoscopy (2009) 1.02
Invasion of campylobacter-like organisms in the duodenal mucosa in patients with active duodenal ulcer. Klin Wochenschr (1987) 1.02
Expression of carbonic anhydrase IX in human pancreatic cancer. Aliment Pharmacol Ther (2003) 1.01
alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives. Gut (2000) 1.01
Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer (2002) 1.00
Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur J Clin Microbiol Infect Dis (1998) 1.00
A metastatic endocrine-neurogenic tumor of the ampulla of Vater with multiple endocrine immunoreaction--malignant paraganglioma? Digestion (1985) 1.00